Valneva SE (VALN) Operating Expenses (2021 - 2026)

Valneva SE (VALN) posted quarterly Operating Expenses of -$21.8 million for Q1 2026, up 2.7% year-on-year from -$21.3 million in Q1 2025, and down 108.87% on a QoQ basis from $246.0 million in Q4 2025.

Valneva SE (VALN) Operating Expenses (2021 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Operating Expenses for 6 consecutive years, with -$21.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Operating Expenses rose 2.7% year-over-year to -$21.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $159.4 million (up 5.17% YoY) and the FY2025 annual result came in at $158.8 million, up 6.03% from the prior year.
  • Operating Expenses declined to -$21.8 million in Q1 2026 per VALN's latest filing, from $246.0 million in the prior quarter.
  • Over the last five years, Operating Expenses for VALN reached as high as $12.0 billion in Q3 2022 and fell as low as -$11.8 billion in Q4 2022.
  • A 5-year average of $34.6 million and a median of -$25.0 million in 2023 frame the typical range for Operating Expenses.
  • The largest YoY upside for Operating Expenses was 21503.18% in 2022 against a maximum downside of 2893.33% in 2022.
  • Year by year, Operating Expenses stood at -$11.8 billion in 2022, then surged by 101.82% to $214.4 million in 2023, then gained by 7.24% to $229.9 million in 2024, then rose by 7.01% to $246.0 million in 2025, then sank by 108.87% to -$21.8 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered -$21.8 million, $246.0 million, and -$38.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -28.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.10 Bn
4 NuCana 279.75 Bn 279.75 Bn - -3.78 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.85 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 32.68 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 2.89 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 445.22 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn -21.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -21.83 Mn
Dec 31, 2025 246.00 Mn
Sep 30, 2025 -38.21 Mn
Jun 30, 2025 -26.58 Mn
Mar 31, 2025 -22.44 Mn
Dec 31, 2024 229.88 Mn
Sep 30, 2024 -28.32 Mn
Jun 30, 2024 -27.57 Mn
Mar 31, 2024 -24.24 Mn
Dec 31, 2023 214.37 Mn
Sep 30, 2023 -28.91 Mn
Jun 30, 2023 -25.01 Mn
Mar 31, 2023 -24.47 Mn
Dec 31, 2022 -11.75 Bn
Sep 30, 2022 12.00 Bn
Jun 30, 2022 -47.17 Mn
Mar 31, 2022 -30.11 Mn
Dec 31, 2021 420.80 Mn
Sep 30, 2021 -56.05 Mn
Jun 30, 2021 -70.44 Mn